MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-09-2025
Tilray Historical Prices 2011-2026 | TLRY
Annual Historical Prices Tilray
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.93 | 3.55 | 7.03 | 8.26 | 17.1 | 70.5 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.5 | 1.93 | 18.1 |
Historical Prices of other stocks in the Drug manufacturers industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M |  USA |
 |
Canopy Growth Corporation
CGC
|
1.32 | $ 1.18 | 3.07 % | $ 127 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
3.69 | $ 2.65 | 0.57 % | $ 1.39 B | Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
60 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | USA |
 |
Aurora Cannabis
ACB
|
4.08 | $ 4.3 | 1.87 % | $ 86.3 M | Canada |
 |
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
2.71 | $ 12.3 | -0.49 % | $ 630 M | USA |
 |
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | USA |
 |
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
7.54 | $ 21.52 | -0.14 % | $ 2.05 B |  France |
 |
Organogenesis Holdings
ORGO
|
3.15 | $ 4.92 | -5.01 % | $ 648 M | USA |
 |
Pacira BioSciences
PCRX
|
25.5 | $ 25.08 | -3.09 % | $ 1.16 B | USA |
 |
Evolus
EOLS
|
14.3 | $ 6.69 | 0.6 % | $ 415 M | USA |
 |
Harrow Health
HROW
|
10.7 | $ 47.88 | -2.29 % | $ 1.56 B | USA |
 |
China Pharma Holdings
CPHI
|
0.26 | $ 1.23 | 1.64 % | $ 21.5 M |  China |
 |
Sundial Growers
SNDL
|
1.45 | $ 1.68 | 1.14 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 3.57 | -1.8 % | $ 4.43 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | Canada |
 |
OrganiGram Holdings
OGI
|
1.58 | $ 1.72 | 2.08 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
9.27 | $ 6.98 | 0.43 % | $ 2.55 B | Canada |
 |
Lannett Company
LCI
|
0.57 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
6.3 | $ 3.85 | -3.27 % | $ 54.1 M | USA |
 |
Veru
VERU
|
0.8 | $ 2.18 | 1.87 % | $ 294 M | USA |
 |
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
1.52 | $ 0.86 | 1.99 % | $ 20.1 M | USA |
 |
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
28.8 | $ 13.86 | -0.47 % | $ 1.9 B | USA |
 |
ProPhase Labs
PRPH
|
8.24 | $ 0.45 | 0.36 % | $ 7.13 M | USA |
 |
cbdMD
YCBD
|
0.39 | $ 1.16 | -14.44 % | $ 5 M | USA |
 |
Recro Pharma
REPH
|
1.4 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
5.37 | $ 4.55 | -5.8 % | $ 137 M | USA |
 |
OptiNose
OPTN
|
1.71 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
0.93 | $ 9.3 | 2.54 % | $ 661 M | USA |
 |
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
5.53 | $ 5.49 | -2.66 % | $ 224 M | USA |
 |
SCYNEXIS
SCYX
|
1.47 | $ 0.62 | -1.96 % | $ 29.7 M | USA |
 |
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
2.29 | $ 1.62 | -0.61 % | $ 16.9 M | USA |
 |
Viatris
VTRS
|
11.2 | $ 12.36 | -0.76 % | $ 15 B | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | USA |